Medpace Holdings, Inc. 4

Fred B. Davenport Jr. exercised options to acquire 7,583 Medpace Holdings, Inc. (MEDP) shares and sold 7,283 shares on August 19, 2026.

On August 19, 2026, Medpace Holdings, Inc. insider Fred B. Davenport Jr. exercised three tranches of stock options for an aggregate 7,583 shares of Common Stock at strike prices of $84.36, $133.87, and $164.68 per share, and on the same date sold 7,283 shares in the open market at a weighted average price of $606.15 per share (with sales occurring between $605.59 and $607.202). The option exercises resulted in 1,903, 3,858, and 1,822 shares being acquired, all recorded as directly owned, while the subsequent sale reduced his direct holdings but left him still owning 3,798 shares of Common Stock directly after the transactions. He also reports 2,000 shares of Common Stock held indirectly by a trust for his benefit. The sale appears structured as a liquidity or tax‑related event contemporaneous with the option exercises, rather than a pure discretionary sale of long‑held stock.

Filing Facts

CIK

1668397

Ticker

MEDP

Form

4

Source Type

fda

Accession

0000892251-26-000123

Alert Tier

7